ICEQX
Price
$22.24
Change
-$0.31 (-1.37%)
Updated
Jun 13 closing price
Net Assets
3.77B
VTSAX
Price
$142.91
Change
-$1.69 (-1.17%)
Updated
Jun 13 closing price
Net Assets
1.82T
Interact to see
Advertisement

ICEQX vs VTSAX

Header iconICEQX vs VTSAX Comparison
Open Charts ICEQX vs VTSAXBanner chart's image
Macquarie Core Equity Fund Class R6
Price$22.24
Change-$0.31 (-1.37%)
VolumeN/A
Net Assets3.77B
Vanguard Total Stock Mkt Idx Adm
Price$142.91
Change-$1.69 (-1.17%)
VolumeN/A
Net Assets1.82T
ICEQX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ICEQX vs. VTSAX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICEQX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.82T vs. ICEQX (3.77B). VTSAX pays higher dividends than ICEQX: VTSAX (1.28) vs ICEQX (0.33). ICEQX was incepted earlier than VTSAX: ICEQX (11 years) vs VTSAX (25 years). ICEQX (0.70) is less costly to investors than VTSAX (0.04). ICEQX is a more actively managed with annual turnover of: 35.00 vs. VTSAX (2.00). ICEQX has a lower initial minimum investment than VTSAX: ICEQX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 10.07 vs. ICEQX (2.35). VTSAX return over 5 years is better than : 91.40 vs. ICEQX (43.41).
ICEQXVTSAXICEQX / VTSAX
Total Expense Ratio0.670.041,675%
Annual Report Gross Expense Ratio0.700.041,750%
Fund Existence11 years25 years-
Gain YTD3.3461.365245%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.77B1.82T0%
Annual Yield % from dividends0.331.2825%
Returns for 1 year2.3510.0723%
Returns for 3 years26.2057.6145%
Returns for 5 years43.4191.4047%
Returns for 10 years46.30179.5326%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP2.840.02
+0.71%
GT Biopharma
GMAB22.82-0.27
-1.17%
Genmab A/S ADS
FINW14.36-0.24
-1.64%
FinWise Bancorp
CENT34.21-1.31
-3.69%
Central Garden & Pet Company
CDLX1.51-0.09
-5.63%
Cardlytics